ADAR1 Capital Management »

Spdr Ser Tr 1 3 hgh yield shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Spdr Ser Tr 1 3 hgh yield (BIL) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Spdr Ser Tr 1 3 hgh yield

Tip: Access up to 7 years of quarterly data

All positions including Spdr Ser Tr 1 3 hgh yield held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spdr Ser Tr 1 3 hgh yield by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0M 33k 91.80
2023-12-31 $2.9M 32k 91.39

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Spdr Ser Tr 1 3 hgh yield

Morgan Stanley
Bank of America Corporation
LPL Financial
Envestnet Asset Management
Wells Fargo & Company
Royal Bank of Canada
Branch Banking & Trust Company
Stifel Financial
Capital Wealth Planning
Capital Research and Management Company - Division 3
Captrust Financial Advisors
Cetera Investment Advisers
Advisor Group Holdings
Partners Capital Investment Group
Beacon Capital Management

View all funds holding Spdr Ser Tr 1 3 hgh yield